Frankfurt
12.06.26 | 15:25
0,108 Euro
-3,57 % -0,004
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.06. | LEE'S PHARM Synthetic Surfactant Project Receives Funding from Gates Foundation | 2 | AASTOCKS | ||
| 01.06. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - FUNDING APPROVED FOR SYNTHETIC SURFACTANT PROJECT | 1 | HKEx | ||
| 27.05. | Dividendenbekanntmachungen (27.05.2026) | 7.475 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAC TECHNOLOGIES HOLDINGS INC ADR US0003041052 0,0446 USD 0,0384 EUR ADVANCE TERRAFUND REIT BG1100025052 - 0,065 EUR APOTEA AB SE0023313762 0... ► Artikel lesen | |
| 21.05. | LEE'S PHARM (00950): ANNUAL GENERAL MEETING HELD ON 21 MAY 2026 - POLL RESULTS | 1 | HKEx | ||
| 11.05. | LEE'S PHARM (00950): CONNECTED TRANSACTION - INVESTMENT IN PARTNERSHIP FUND | 1 | HKEx | ||
| 24.04. | LEE'S PHARM (00950): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM | - | HKEx | ||
| LEES PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
| 24.04. | LEE'S PHARM (00950): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM | 2 | HKEx | ||
| 23.04. | LEE'S PHARM (00950): PROXY FORM | - | HKEx | ||
| 23.04. | LEE'S PHARM (00950): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.04. | LEE'S PHARM (00950): GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.04. | LEE'S PHARM (00950): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 | 1 | HKEx | ||
| 23.04. | LEE'S PHARM (00950): ANNUAL REPORT 2025 | - | HKEx | ||
| 30.03. | LEE'S PHARM (00950): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 | 1 | HKEx | ||
| 30.03. | Lee's Pharmaceutical Holdings Ltd. Reports Retreat In Full Year Bottom Line | 1 | RTTNews | ||
| 30.03. | LEE'S PHARM (00950): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025 | - | HKEx | ||
| 25.03. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - APPROVAL OF INTRAROSA BY NMPA | - | HKEx | ||
| 17.03. | LEE'S PHARM (00950): NOTICE OF BOARD MEETING | 5 | HKEx | ||
| 27.01. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION FOR ADASUVE | - | HKEx | ||
| 22.12.25 | LEE'S PHARM (00950): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DISCLOSEABLE TRANSACTION - ACQUISITION OF ASSETS | 5 | HKEx | ||
| 18.12.25 | LEE'S PHARM (00950): PASSING AWAY OF MICHELE DALLA LIBERA | 1 | HKEx |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 108,44 | -0,07 % | Zelltherapien rücken in den Mittelpunkt: Warum Mesoblast von einem grundlegenden Wandel in der Biotechnologie profitieren könnte | ||
| ZOETIS | 69,00 | +0,35 % | Zoetis (ZTS) Stock Dips While Market Gains: Key Facts | ||
| SINOPHARM | 1,853 | -1,12 % | Reed Sinopharm Exhibitions (RSE): PCHi 2026: World's Largest Cosmetics Ingredients Exhibition Opens in Hangzhou | 860+ exhibitors from 26 countries and regions across 70,000 sqmClose to 50 new product launches, including global and China debuts295 product submissions and 19 engineer nominations for the... ► Artikel lesen | |
| CSPC PHARMA | 0,816 | +1,53 % | CSPC PHARMA KN026 Combined with HB1801 for Breast Cancer Meets Primary Endpoint | ||
| WUXI BIOLOGICS | 3,355 | -0,89 % | WUXI BIO (02269): NEXT DAY DISCLOSURE RETURN | ||
| SHANGHAI FOSUN PHARMACEUTICAL | 1,784 | +1,77 % | Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution | SHANGHAI, April 28, 2026 /PRNewswire/ -- On 28 April, Fosun Pharma ("the Company", stock code: 600196.SH; 02196.HK) announced its results for the first quarter... ► Artikel lesen | |
| GEDEON RICHTER | 33,160 | -0,54 % | Gedeon Richter Plc.: Extraordinary Information | ||
| DR REDDYS | 11,400 | 0,00 % | Dr. Reddy's Labs oncology drug Bosutinib Tablets in United States | ||
| MEDIPHARM LABS | 0,040 | -11,11 % | MediPharm Labs Corp.: MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA | Q1 2026 Positive Adjusted EBITDA(1)Net Revenue of $9M with strong gross margins of 37%OPEX decreased 28% in Q1 2026 versus Q4 2025Company is virtually debt free, with a Q1 ending cash balance of $9.9... ► Artikel lesen | |
| ASPEN PHARMACARE | 7,650 | 0,00 % | ASPEN PHARMACARE HOLDINGS LIMITED - Completion of the divestment of Aspen APAC | ||
| SHANGHAI PHARMACEUTICALS | 1,260 | 0,00 % | Dividendenbekanntmachungen (29.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADWAYS INC JP3121970002 6,35 JPY 0,0344 EUR AGC INC JP3112000009 105 JPY 0,5701 EUR AMERICAN TOWER CORPORATION US03027X1000 1... ► Artikel lesen | |
| LUYE PHARMA | 0,208 | -0,95 % | LUYE PHARMA (02186): COMPLETION OF CONCURRENT REPURCHASE OF US$180,000,000 6.25 PER CENT. CONVERTIBLE BONDS DUE 2028 | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,103 | +3,52 % | SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE SHARE AWARD SCHEME | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,525 | -2,78 % | CHINARES PHARMA (03320): POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 12 JUNE 2026 | ||
| HANSOH PHARMACEUTICAL | 3,252 | +2,59 % | HANSOH PHARMA HS-10568 Injection NDA Accepted |
LEES PHARMACEUTICAL HOLDINGS LTD gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von -0,004 (-3,57 %) liegt der Kurs bei 0,108 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LEES PHARMACEUTICAL HOLDINGS LTD finden Sie auf Wallstreet Online.